<em>In silico</em> pharmacokinetic and toxicological study of Flavone analogues
Estudo farmacocinético e toxicológico in silico de análogos de Flavonas
DOI:
https://doi.org/10.34117/bjdv8n12-263Keywords:
natural products, Flavonoids, Flavones, chemoinformatics, in silico ADME, in silico-ToxicologyAbstract
Flavone analogs are natural compounds of the flavonoid class that have a wide range of biological activities. The present study aimed to predict, with the aid of in silico methodologies, the oral bioavailability and pharmacokinetic and toxicological analyzes for three flavone analogues (apigenin, chrysin and luteonlin). The study revealed that the analogues have good oral availability, favorable pharmacokinetic and toxicological parameters. The Virtual Screening performed to predict oral bioavailability revealed that all analogues did not violate Lipinski's Rule. The in silico pharmacokinetic study revealed that all analogues have high intestinal absorption, do not cross the blood-brain barrier, are permeable by Caco-2 cells and do not inhibit P-glycoprotein. The in silico ADME study showed that all analogues inhibit the enzymes of the cytochrome P450 complex (CYP4501A2, CYP4502C9, CYP4502C19, CYP4503A4) and not only the CYP4502D6 enzyme. The in silico Toxicology study indicated that the analogues do not show toxicity by the AMES Test and are not carcinogenic. Apigenin and chrysin have low toxicity, while luteolin has moderate toxicity.
References
ACD/Advanced Chemistry Development, Inc. ChemSketch® Freeware, version 2021.
AMES, B. N.; DURSTON, WILLIAM E.; YAMASAKI, EDITH; LEE, F. D. Carcinogens are Mutations: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection. Proceedings of the National Academy of Sciences, (8), pp. 2281-2285, 1973.
AMIN, L. P-glycoproteininhibition for optimal drug delivery, Drug Targets Insights, 7, p. 27-34, 2013.
ASHORAJ, Y.; DEY, C. S.; PANCHAGNULA, R.; VARMA, M. V. S. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res., 48 (4), p. 347-359, 2003.
BAE, Y.; LEE, S.; KIM, S. H. Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-kappaB. Toxicology and Applied Pharmacology, v. 254, p. 56-64, 2011.
CATHERINE, A. R.; PACKER, L. Flavonoids in health and disease. 2nd ed., Basel Copyright: New York, 2003.
COWAN, N. An Embedded Process Model of Working Memory. In: Miyake, A. and Shah, P., Eds., Models of Working Memory: Mechanisms of Active Maintenance and Executive Control, Cambridge University Press, 62-101, 1999.
DE MONTELLANO, P. R. O. Cytochrome P450: Structure, Mechanism, and Biochemistry. Oh, Ed. Springer Science & Business Media, 2010.
DEVLIN, THOMAS. Manual of Biochemistry with Clinical Correlations. Translation of the sixth American edition, Editora Blucher, São Paulo, 2002.
DOLABELA, M. F.; SILVA, A. R. P. D.; OHASHI, L. H.; BASTOS, M. L. C.; SILVA, M. C. M. D.; VALE, V. Silico study of the activities of triterpenes and iridoids isolated from Himatanthus articulatus (Vahl) Woodson, Revista Fitos, 2018.
FIALHO, S. N. Leishmanicidal activity of synthetic derivatives of cinnamic acid against Leishmania amazonensis in vitro. Porto Velho, RO, Brazil, TCC (Graduation) - Bachelor of Biological Sciences Course, 2017.
FLAMBÓ, D. Biological Activities of Flavonoids: Antimicrobial Activity. Porto, Portugal, Master's thesis, 2015.
FONSECA, K. Z.; PRAZERES, A. G. M.; LIMA, C. L. B.; SANTOS, I. P.; PAMPONET, J. S. S. Frequently asked questions about Flavonoids. 1st ed., University Library of Cruz das Almas, BA, Brazil, 2016.
GALLI, E.; FEIJOO, L. Cytochrome p-450 y su importancia clinic revisión updated. Journal of Neuropsychiatry, 2002.
GOLAN, D. E.; TASHJIAN JR, A. H.; ARMSTRONG, E. J.; ARMSTRONG, A, W. Principles of Pharmacology: the physiopathological basis of pharmacology. Rio de Janeiro: Guanabara Koogan, 2017.
GONÇALVES, R. O. Synthesis of esters derived from cinnamic, p-methoxycinnamic and ferulic acid and evaluation of cytotoxicity. Fortaleza, CE, Brazil, Master's thesis, 2020.
GROB, S. Molinspiration Cheminformatics: Cheminformatics on the Web, NOVARTIS: Bratislava University, Slovak Republic, 1986; available at http://www.molinspiration.com/
HARBONE, J. B.; WILLIAMS, C. A. Advances in Flavonoid Research since 1992. Phytochemistry, 55, 481-504, 2000.
JOHN, J. E. Natural products as lead-structures: a role for biotechnology. Drug Discovery Today, v. 15, pp. 409-410, 2010.
KANAZAWA, T. Development of noninvasive drug delivery systems to the brain for the treatment of brain/central nervous system diseases. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan, 138 (4), 443-450, 2018.
KAUFFMANN, K.; GREMM, L.; BRENDT, J.; SCHIWY, A.; BLUHM, K.; HOLLERT, H.; BUCHS, J. Alternative type of Ames testallows for dynamics mutagenicity detection by online monitoring of respiration activity. Science of The Total Environment, 726, 2020.
LORENZONI, A. Development of nanocapsules for controlled release of chrysin: evaluation of antioxidant activity and cytotoxicity in vitro. Santa Maria, RS, Brazil, Master's thesis, 2015.
MACHADO, H.; NAGEM, T. J.; PETERS, V. M.; FONSECA, C. S.; OLIVEIRA, T. T. Flavonoides and their therapeutic potential. Bulletin of the Reproduction Biology Center, Juiz de Fora, MG, Brazil, v. 26, pp. 37-44, 2008.
MATOS, K. S. Computational and experimental studies of the cellular permeability of drug candidates, University of São Paulo, São Paulo, SP, Brazil, Doctoral Thesis, 2017.
MIRANDA, C. C. S.; SALAZAR, V. A. C.; BRITO, M. D. R. M. Evaluation in silico of the antifungal activity of sulphurised compounds present in Petiveria alliacea L.
Molinspiration - cheminformatics. Available at: www.molinspiration.com. Accessed: 30/09/2022.
MORRIS, G. M.; LIM-WILBY, M. Molecular docking. Molecular modeling of proteins. Humana Press, pp. 365-382, 2008.
Norgwyn Montgomery Software: ChemSW® Inc.; Molecular Modeling Pro Plus Version 8.0, Computational Chemistry Program; Fairfield, 2017.
POLLI, J. E.; CRISON, J. R.; AMIDON, G. L. Novel approach to the analysis of in vitro and in vivo J. Pharm. Sci., v. 85, p. 753-761, 1996.
PUSHPAVALLI, G.; KALAIARASI, P.; VEERAMANI, C.; PUGALENDI, K. V. Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. European Journal of Pharmacology, v. 631, p.36-41, 2010.
RODRIGUES, P. J. Effect of cinnamic acid on acute inflammatory response. Maringá, PR, Brazil, Master's Dissertation, 2016.
SANT'ANNA, Carlos M. R. Molecular Modeling Methods for the Study and Planning of Bioactive Compounds: An Introduction. Rev. Virtual Quim., 1 (1), 49-57. 2009.
SHAOHAIB, T.; SHAFIQUE, M.; DHANYA, N.; DIVAKAR, M.C. Importance of Flavonoids in Therapeutics. Journal of Drugs and Medicines, 3 (1), p. 1 - 18, 2011.
SHARMA, G.; LAKKADWALA, S.; MODGIL, A.; SINGH, J. The role of cell-penetrating peptide and transferrin on enhanced delivery of drugs to the brain. International journal of molecular sciences, 17 (6), 806, 2016.
SHIMOI, K.; OKADA, H.; FURUGONI, M.; GODA, T.; TAKASE, S.; SUZUKI, M.; HARA, Y.; YAMAMOTO, H.; KINAE, N. Intestinal Absorption of Luteolin and Luteolin 7-O-β-Glucoside in Rats and Humans. FEBS Letters, 438, 220-224, 1998.
SHUKLA, M.; GUPTA, R. Performance Analysis of Optimum Interleaver based on Prime Numbers for Multiuser Iterative IDMA Systems. International Journal of Interdisciplinary Telecommunications and Networking (IJITN), 2, 51-65, 2010.
SILVADO C. E.; TERRA, V. C.; TWARDOWSCHY, C. A. CYP2C9 polymorphisms in epilepsy: influence on the treatment of phenytoin. Pharmacogenomics Med., 11, 51-58, 2018.
SIMÕES, C. M. O.; SCHENKEL, E. P.; GOSMANN, G.; MELLO, J. C. P.; MENTZ, L. A.; PETROVICK, P. R. Pharmacognosia: from plant to medicinal product. 6st. ed., Porto Alegre, UFRGS Publishing House, 2007.
SOUSA, M. C. D. Molecular modeling studies for In Silico prediction of probable flavonoid phase I metabolites, Federal University of Goiás, Goiânia, GO, Brazil, Master's thesis, 2012.
SOUZA, J. S. DE. Esterification of cinnamic acid using enzymatic catalysis. TCC (Graduation) - Degree in Chemistry, Federal Institute of Education, Science and Technology of Rio Grande do Norte, 2021.
THOMPSON, M. Arguslab® Freeware version 4.0, Mark Thompson and Planaria Software, LLC., 1997.
VEBER, D. F.; JOHNSON, S. R.; CHENG, H-Y.; SMITH, B.R.; WARD, K. W.; KOPPLE, K. D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem., v.45, p.2615-2623, 2002.
WANG! Y.; XING J.; XU Y.; ZHOU N.; PENG J.; XIONG Z.; LIU X.; LUO X.; LUO C.; CHEN K.; ZHENG M.; JIANG H. In silico ADME/T modeling for rational drug design. Fourth. Rev. Biophys., 48, 488-515, 2015.
YAKAIAH, C.; SNEHA, T.; SHALINI, T.; SRINIVAS, C.; ANAND, K. D.; NIRANJANA, K. A.; SRINIVAS. K. V. N. S.; SARFARAZ. A.; KOTESH. K.J.; FIERCE. K.; ASHOK. T. P. G. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. European Journal of Medicinal Chemistry, 93, 564-573, 2015.
YANG, H.; SUN, L.; LI, W.; LIU, G.; TANG, Y. In silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts. Front. Chem., 6, 30, 2018.
ZARZECKI, M. S.; ARAUJO, S.M.; BORTOLOTTO, V. C.; DE PAULA, M. T.; JESSE, C. R.; PRIGOL, M. Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Toxicology Reports, 1, p. 200-208, 2014.
ZHOU X.; WANG F.; ZHOU R.; SONG X.; XIE M. Apigenin: A current review on its beneficial biological activity. Journal Of Food Bio-Chemistry, v. 41, 2017.
